Global Stem Cell and Regenerative Medicine Market Demand Analysis & Opportunity Report 2018: Market is Expected to Garner USD 14.74 Billion by the End of 2024

DUBLIN, Oct. 22, 2018 /PRNewswire/ --

The "Stem Cell and Regenerative Medicine Market: Global Demand Analysis & Opportunity Outlook 2024" report has been added to ResearchAndMarkets.com's offering.

The global stem cell and regenerative medicine market reached USD 10,200 Million in 2016 by registering a CAGR of 4.8% across the globe. Moreover, the market is expected to garner USD 14745.7 Million by the end of 2024.

The global demand for stem cell and regenerative medicine is increasing due to the increase in old age population globally. Further, growing awareness towards stem cell and regenerative medicine is key growth driver for global stem cell and regenerative medicine market over the forecast period.

North America is slated to account for a leading share of 39.7% by 2024 in the stem cell and regenerative medicine market. The growth in the region can be attributed to presence of well-established healthcare industry along with expanded funding from the governments organizations. Besides, in 2015, U.S. health care spending increased 5.8% to reach USD 3.2 trillion which is also expected to impel the growth of stem Cell and regenerative medicine market in the North America. U.S. is the prominent market driving the growth in the region.

Additionally, U.S. stem cell and regenerative medicine market reached USD 3442 Million in 2016 and is expected to reach USD 5056.4 Million by the end of 2024, expanding at a CAGR of 4.9% over the forecast period i.e. 2017-2024. U.S. stem Cell and regenerative medicine market is expected to achieve Y-o-Y growth rate of 5.6% in 2024 as compared to previous year.

Europe market is expected to expand at a significant CAGR of 4.9% during the forecast period i.e. 2017-2024. Growth and expansion of pharmaceutical industry in the region is expected to be the key factor behind the growth of stem Cell and regenerative medicine market in the Europe region. Further, increasing application of stem Cell and regenerative medicine is expected to fuel the growth of Europe stem Cell and regenerative medicine market during the forecast period. France & Germany are the major contributor to the growth of stem Cell and regenerative medicine market.

Global stem cell and regenerative medicine market is segmented on the basis of product into adult stem cells, human embryonic stem cells, induced pluripotent stem cells, and very small embryonic like stem cells. Among these segments, adult stem cells segment (82.9% share in 2016) occupies the largest market of stem cell and regenerative medicine across the globe. Further, global adult stem cells market is anticipated to reach USD 12,290.1 Million by the end of 2024 from USD 8,456.6 Million in 2016. Moreover, this segment is anticipated to flourish at a CAGR of 4.9% over the forecast period. In addition, wide scale application of adult stem cells in the cell regeneration of various diseases is expected to supplement the growth of global adult stem cells market.

In end-user segment, the pharmaceutical industry segment is estimated to remain highest during the forecast period. This segment contributed around 82.9% market share of total stem Cell and regenerative medicine market in 2016. Further, this segment is projected to capture 83.1% market share by 2024. Further, pharmaceutical industry segment is projected to achieve Y-o-Y growth rate of 5.5% in 2024 as compared to previous year.

STEMCELL Technologies Inc., AMAG Pharmaceuticals Inc., Osiris Therapeutics, Inc., are some of the prominent players of stem cell and regenerative medicine market.

Key Topics Covered:

1. Executive Summary

2. Research Methodology

3. Risk Analysis

3.1. Demand Risk

3.2. Supply Risk

4. Top Countries with Highest demand for Stem Cell & Regenerative Medicine - By Region

4.1. North America

4.2. Europe

4.3. Asia-Pacific

4.4. Middle East & Africa

5. Global Stem Cell & Regenerative Medicine Market Size (USD Million) and Forecast, 2016-2024

6. Market Dynamics & Its Impact Analysis

6.1. Growth Drivers

6.2. Challenges

6.3. Trends

6.4. Opportunities

7. Global Market Segmentation Analysis

7.1. By Product Type Market Size (USD Million) & Y-O-Y Growth Analysis (%), 2016-2024

7.1.1. Adult Stem Cells Market Size (USD Million) & Y-O-Y Growth Analysis (%), 2016-2024

7.1.1.1. Neural Stem Cells Market Size (USD Million) & Y-O-Y Growth Analysis (%), 2016-2024

7.1.1.2. Hematopoietic Stem Cells Market Size (USD Million) & Y-O-Y Growth Analysis (%), 2016-2024

7.1.1.3. Mesenchymal Stem Cells Market Size (USD Million) & Y-O-Y Growth Analysis (%), 2016-2024

7.1.1.4. Umbilical Cord Stem Cells Market Size (USD Million) & Y-O-Y Growth Analysis (%), 2016-2024

7.1.1.5. Epithelial Stem cells and Skin Stem Cells Market Size (USD Million) & Y-O-Y Growth Analysis (%), 2016-2024

7.1.1.6. Others Market Size (USD Million) & Y-O-Y Growth Analysis (%), 2016-2024ers

7.1.1.7. Human Embryonic Stem Cells Market Size (USD Million) & Y-O-Y Growth Analysis (%), 2016-20247.1.2. Induced Pluripotent Stem Cells Market Size (USD Million) & Y-O-Y Growth Analysis (%), 2016-2024

7.1.3. Very Small Embryonic Like Stem Cells Market Size (USD Million) & Y-O-Y Growth Analysis (%), 2016-2024

7.1.4. Market Attractiveness By Product Type

7.1.5. BPS Analysis By Product Type

7.2. By Application Market Size (USD Million) & Y-O-Y Growth Analysis (%), 2016-2024

7.2.1. Regenerative Medicine Market Size (USD Million) & Y-O-Y Growth Analysis (%), 2016-2024

7.2.1.1. Neurology Market Size (USD Million) & Y-O-Y Growth Analysis (%), 2016-2024

7.2.1.2. Oncology Market Size (USD Million) & Y-O-Y Growth Analysis (%), 2016-2024

7.2.1.3. Cardiovascular & Myocardial Infraction Market Size (USD Million) & Y-O-Y Growth Analysis (%), 2016-2024

7.2.1.4. Diabetes Market Size (USD Million) & Y-O-Y Growth Analysis (%), 2016-2024

7.2.1.5. Hematology & Immunology Market Size (USD Million) & Y-O-Y Growth Analysis (%), 2016-2024

7.2.1.6. Orthopedics Market Size (USD Million) & Y-O-Y Growth Analysis (%), 2016-2024

7.2.1.7. Others Market Size (USD Million) & Y-O-Y Growth Analysis (%), 2016-2024

7.2.2. Drug Discovery and Development Market Size (USD Million) & Y-O-Y Growth Analysis (%), 2016-2024

7.2.3. Market Attractiveness By Application

7.2.4. BPS Analysis By Application

7.3. By Technology Market Size (USD Million) & Y-O-Y Growth Analysis (%), 2016-2024

7.3.1. Cell Acquisition Market Size (USD Million) & Y-O-Y Growth Analysis (%), 2016-2024

7.3.1.1. Bone Marrow Harvest Market Size (USD Million) & Y-O-Y Growth Analysis (%), 2016-2024

7.3.1.2. Umbilical Cord Blood Market Size (USD Million) & Y-O-Y Growth Analysis (%), 2016-2024

7.3.1.3. Apheresis Market Size (USD Million) & Y-O-Y Growth Analysis (%), 2016-2024

7.3.1.4. Others Market Size (USD Million) & Y-O-Y Growth Analysis (%), 2016-2024

7.3.2. Cell Production Market Size (USD Million) & Y-O-Y Growth Analysis (%), 2016-2024

7.3.2.1. Therapeutic Cloning Market Size (USD Million) & Y-O-Y Growth Analysis (%), 2016-2024

7.3.2.2. IVF Market Size (USD Million) & Y-O-Y Growth Analysis (%), 2016-2024

7.3.2.3. Cell Culture Market Size (USD Million) & Y-O-Y Growth Analysis (%), 2016-2024

7.3.2.4. Isolation Market Size (USD Million) & Y-O-Y Growth Analysis (%), 2016-2024

7.3.3. Cryopreservation Market Size (USD Million) & Y-O-Y Growth Analysis (%), 2016-2024

7.3.4. Expansion and Sub-Culture Market Size (USD Million) & Y-O-Y Growth Analysis (%), 2016-2024

7.4. By End Use Market Size (USD Million) & Y-O-Y Growth Analysis (%), 2016-2024

7.4.1. Hospitals Market Size (USD Million) & Y-O-Y Growth Analysis (%), 2016-2024

7.4.2. Medical Industry Market Size (USD Million) & Y-O-Y Growth Analysis (%), 2016-2024

7.4.3. Research Institutes Market Size (USD Million) & Y-O-Y Growth Analysis (%), 2016-2024

7.4.4. Market Attractiveness By End Use

7.4.5. BPS Analysis By End Use

7.5. By Region Market Size (USD Million), Y-O-Y Growth & Share Analysis (%), 2016-2024

8. Porter's Five Force Model Analysis

9. Competitive Landscape

9.1. Competitive Positioning of Major Players in Global Stem Cell & Regenerative Medicine Market

9.2. Company Profiles

9.2.1. Sangamo Therapeutics

9.2.2. Pluristem Therapeutics

9.2.3. BIOTIME, Inc.

9.2.4. Takara Bio Inc

9.2.5. Cellular Engineering Technologies Inc.

9.2.6. Thermo Fisher Scientific Inc.

9.2.7. Athersys Inc.

9.2.8. Osiris Therapeutics, Inc

9.2.9. STEMCELL Technologies Inc

9.2.10. AMAG Pharmaceuticals, Inc.

For more information about this report visit https://www.researchandmarkets.com/research/g6jlbd/global_stem_cell?w=5

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:

Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com